XML 15 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
STATEMENTS OF CONSOLIDATED INCOME (LOSS) - USD ($)
shares in Thousands, $ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]      
Net sales $ 3,087.0 $ 3,427.9 $ 2,622.0
Costs and expenses:      
Cost of products sold, excluding depreciation and amortization 2,754.9 3,180.2 2,348.1
Depreciation and amortization 108.6 106.9 91.5
Selling, general, administrative, research and development 122.7 110.9 118.8
Goodwill impairment 0.0 20.5  
Restructuring costs (benefit) 5.0 2.2 (0.8)
Other operating charges, net   3.2  
Total costs and expenses 2,991.2 3,423.9 2,557.6
Operating income 95.8 4.0 64.4
Other (expense) income:      
Interest expense (46.9) (48.3) (49.5)
Other income (expense), net - Note 13 7.4 6.4 (38.9)
Income (loss) before income taxes 56.3 (37.9) (24.0)
Income tax (provision) benefit (9.1) 8.3 5.5
Net income (loss) $ 47.2 $ (29.6) $ (18.5)
Net income (loss) per common share:      
Basic $ 2.95 $ (1.86) $ (1.17)
Diluted $ 2.92 $ (1.86) $ (1.17)
Weighted-average number of common shares outstanding (in thousands):      
Basic 15,991 15,906 15,836
Diluted 16,131 15,906 15,836